In 2022, Sentinel investigators conducted a large study looking at race and COVID-19 outcomes in the first year of the pandemic. The Sentinel System is routinely used to evaluate post-market utilization and safety of regulated medical products as well as post-market benefits of regulated medical products. This study demonstrated that the Sentinel System can be a resource for supporting broader surveillance on health outcomes in the United States.
The study included around 850,000 individuals with COVID-19 and around 130,000 individuals hospitalized with COVID-19 from across the country from April 2020 to March 2021, making it among the largest studies known to date. After controlling for demographic, clinical, and socioeconomic differences at baseline, the results showed that minoritized groups had increased odds for hospitalization and 30-day mortality following COVID-19 relative to their White counterparts in the United States. American Indian or Alaska Native (AIAN) (Odds Ratio (OR): 1.52 [1.20-1.91]), Asians (OR: 1.30 [1.13-1.49]), and Native Hawaiian or Other Pacific Islander (NHOPI) (OR: 1.24 [1.06-1.45]) had significantly higher odds of 30-day inpatient mortality compared to Whites. Read more about the results here.
|